Review on Therapeutic Uses of Mimosa Pudica (Touch-me-not) Plant

The prostrate or semi-erect subshrub Mimosa pudica L. (Mimosacee), referred to as touch me not, live and die, shame plant, and humble plant, is indigenous to North and South America as well as Australia. They are delicate soft grey green leaves that fold and droop at night or when handled and chilled, and they are thickly equipped with recurved thorns in India. Its peculiar bending behaviors have given it the nickname "curiosity plant." According to Ayurveda, the root of this plant is bitter, acrid, cooling, vulnerary, and alexipharmic. Leprosy, dysentery, vaginal and uterine complaints, inflammations, burning sensations, asthma, leucoderma, tiredness, and blood disorders are among the conditions it is used to treat. It appears to be a prospective herbal candidate deserving of further research, as shown by its pharmacological profile Numerous illnesses, including cancer, diabetes, hepatitis, obesity, and urinary infections, are also prevented or treated using mimosa pudica. It predominantly contains pharmacological activities that include antibacterial, antivenom, antitertility, anticonvulsant, depressant, aphrodisiac, and others. The plant has been used to treat urogenital issues for ages

Review on Calotropis Gigantea as a Topically used Plant

There have been numerous reports of the Asclepiadaceae plant, Calotropis gigantea R.Br, having medicinal and other uses. Plants have been employed as a source of medicinal substances since ancient times. In the indigenous system of medicine, plants are used extensively to treat disease. Traditional medicine makes use of various plant extracts or bioactive substances. This kind of research offers health at a reasonable price. The findings imply that the stem, leaves, and flower's phytochemical qualities can be used to treat a variety of diseases. The nation that produces the most medicinal herbs is India, which is fittingly known as the world's botanical garden. Calotropis gigantea, a member of the Asclepiadaceae/Apocynaceae family, is also referred to as the Crown Flower and has unique therapeutic properties that can be used alone or in conjunction with other medications to treat common disorders. Herbal medicines have a very wide range of medicinal applications. In ayurveda, the entire dried plant is used as a mucus explusor, parasitic worm expeller, and rejuvenator. Leprosy and asthma are treated with its dried root, while vertigo, baldness, hair loss, and rheumatoid arthritis are all treated with its latex. Calotropis is employed for a variety of conventional and homoeopathic treatments. The plant's many parts can be separated and used as medicine to get a variety of benefits

Notes for genera – Ascomycota

Knowledge of the relationships and thus the classification of fungi, has developed rapidly with increasingly widespread use of molecular techniques, over the past 10--15 years, and continues to accelerate. Several genera have been found to be polyphyletic, and their generic concepts have subsequently been emended. New names have thus been introduced for species which are phylogenetically distinct from the type species of particular genera. The ending of the separate naming of morphs of the same species in 2011, has also caused changes in fungal generic names. In order to facilitate access to all important changes, it was desirable to compile these in a single document. The present article provides a list of generic names of Ascomycota (approximately 6500 accepted names published to the end of 2016), including those which are lichen-forming. Notes and summaries of the changes since the last edition of `Ainsworth Bisby's Dictionary of the Fungi' in 2008 are provided. The notes include the number of accepted species, classification, type species (with location of the type material), culture availability, life-styles, distribution, and selected publications that have appeared since 2008. This work is intended to provide the foundation for updating the ascomycete component of the ``Without prejudice list of generic names of Fungi'' published in 2013, which will be developed into a list of protected generic names. This will be subjected to the XIXth International Botanical Congress in Shenzhen in July 2017 agreeing to a modification in the rules relating to protected lists, and scrutiny by procedures determined by the Nomenclature Committee for Fungi (NCF). The previously invalidly published generic names Barriopsis, Collophora (as Collophorina), Cryomyces, Dematiopleospora, Heterospora (as Heterosporicola), Lithophila, Palmomyces (as Palmaria) and Saxomyces are validated, as are two previously invalid family names, Bartaliniaceae and Wiesneriomycetaceae. Four species of Lalaria, which were invalidly published are transferred to Taphrina and validated as new combinations. Catenomycopsis Tibell Constant. is reduced under Chaenothecopsis Vain., while Dichomera Cooke is reduced under Botryosphaeria Ces. De Not. (Art. 59)